Key Insights
- Asymchem Laboratories (Tianjin)'s estimated fair value is CN¥88.45 based on 2 Stage Free Cash Flow to Equity
- Asymchem Laboratories (Tianjin)'s CN¥81.24 share price indicates it is trading at similar levels as its fair value estimate
- Our fair value estimate is 6.2% lower than Asymchem Laboratories (Tianjin)'s analyst price target of CN¥94.33
Does the November share price for Asymchem Laboratories (Tianjin) Co., Ltd. (SZSE:002821) reflect what it's really worth? Today, we will estimate the stock's intrinsic value by taking the expected future cash flows and discounting them to their present value. This will be done using the Discounted Cash Flow (DCF) model. Believe it or not, it's not too difficult to follow, as you'll see from our example!
Companies can be valued in a lot of ways, so we would point out that a DCF is not perfect for every situation. If you still have some burning questions about this type of valuation, take a look at the Simply Wall St analysis model.
The Model
We're using the 2-stage growth model, which simply means we take in account two stages of company's growth. In the initial period the company may have a higher growth rate and the second stage is usually assumed to have a stable growth rate. To begin with, we have to get estimates of the next ten years of cash flows. Where possible we use analyst estimates, but when these aren't available we extrapolate the previous free cash flow (FCF) from the last estimate or reported value. We assume companies with shrinking free cash flow will slow their rate of shrinkage, and that companies with growing free cash flow will see their growth rate slow, over this period. We do this to reflect that growth tends to slow more in the early years than it does in later years.
A DCF is all about the idea that a dollar in the future is less valuable than a dollar today, so we need to discount the sum of these future cash flows to arrive at a present value estimate:
10-year free cash flow (FCF) forecast
2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | |
Levered FCF (CN¥, Millions) | CN¥736.4m | CN¥906.6m | CN¥1.07b | CN¥1.20b | CN¥1.31b | CN¥1.40b | CN¥1.48b | CN¥1.56b | CN¥1.62b | CN¥1.69b |
Growth Rate Estimate Source | Analyst x2 | Analyst x2 | Analyst x1 | Est @ 11.72% | Est @ 9.04% | Est @ 7.17% | Est @ 5.86% | Est @ 4.94% | Est @ 4.30% | Est @ 3.85% |
Present Value (CN¥, Millions) Discounted @ 6.8% | CN¥690 | CN¥795 | CN¥882 | CN¥923 | CN¥942 | CN¥946 | CN¥937 | CN¥921 | CN¥900 | CN¥875 |
("Est" = FCF growth rate estimated by Simply Wall St)
Present Value of 10-year Cash Flow (PVCF) = CN¥8.8b
After calculating the present value of future cash flows in the initial 10-year period, we need to calculate the Terminal Value, which accounts for all future cash flows beyond the first stage. The Gordon Growth formula is used to calculate Terminal Value at a future annual growth rate equal to the 5-year average of the 10-year government bond yield of 2.8%. We discount the terminal cash flows to today's value at a cost of equity of 6.8%.
Terminal Value (TV)= FCF2034 × (1 + g) ÷ (r – g) = CN¥1.7b× (1 + 2.8%) ÷ (6.8%– 2.8%) = CN¥44b
Present Value of Terminal Value (PVTV)= TV / (1 + r)10= CN¥44b÷ ( 1 + 6.8%)10= CN¥23b
The total value is the sum of cash flows for the next ten years plus the discounted terminal value, which results in the Total Equity Value, which in this case is CN¥31b. The last step is to then divide the equity value by the number of shares outstanding. Compared to the current share price of CN¥81.2, the company appears about fair value at a 8.1% discount to where the stock price trades currently. The assumptions in any calculation have a big impact on the valuation, so it is better to view this as a rough estimate, not precise down to the last cent.
The Assumptions
Now the most important inputs to a discounted cash flow are the discount rate, and of course, the actual cash flows. You don't have to agree with these inputs, I recommend redoing the calculations yourself and playing with them. The DCF also does not consider the possible cyclicality of an industry, or a company's future capital requirements, so it does not give a full picture of a company's potential performance. Given that we are looking at Asymchem Laboratories (Tianjin) as potential shareholders, the cost of equity is used as the discount rate, rather than the cost of capital (or weighted average cost of capital, WACC) which accounts for debt. In this calculation we've used 6.8%, which is based on a levered beta of 0.800. Beta is a measure of a stock's volatility, compared to the market as a whole. We get our beta from the industry average beta of globally comparable companies, with an imposed limit between 0.8 and 2.0, which is a reasonable range for a stable business.
SWOT Analysis for Asymchem Laboratories (Tianjin)
- Currently debt free.
- Dividend is in the top 25% of dividend payers in the market.
- Dividend information for 002821.
- Earnings declined over the past year.
- Annual earnings are forecast to grow faster than the Chinese market.
- Current share price is below our estimate of fair value.
- Significant insider buying over the past 3 months.
- Dividends are not covered by cash flow.
- Revenue is forecast to grow slower than 20% per year.
- See 002821's dividend history.
Next Steps:
Valuation is only one side of the coin in terms of building your investment thesis, and it shouldn't be the only metric you look at when researching a company. DCF models are not the be-all and end-all of investment valuation. Preferably you'd apply different cases and assumptions and see how they would impact the company's valuation. For example, changes in the company's cost of equity or the risk free rate can significantly impact the valuation. For Asymchem Laboratories (Tianjin), we've put together three important items you should further research:
- Risks: To that end, you should be aware of the 2 warning signs we've spotted with Asymchem Laboratories (Tianjin) .
- Management:Have insiders been ramping up their shares to take advantage of the market's sentiment for 002821's future outlook? Check out our management and board analysis with insights on CEO compensation and governance factors.
- Other Solid Businesses: Low debt, high returns on equity and good past performance are fundamental to a strong business. Why not explore our interactive list of stocks with solid business fundamentals to see if there are other companies you may not have considered!
PS. The Simply Wall St app conducts a discounted cash flow valuation for every stock on the SZSE every day. If you want to find the calculation for other stocks just search here.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.